Author

Ratana Lim

Walter and Eliza Hall Institute of Medical Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:long-read sequencing· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Clare L. ScottiD· 2 shared Alicia OshlackiD· 1 shared Anna DeFazioiD· 1 shared Anthony T. PapenfussiD· 1 shared Binny JaradiiD· 1 shared Breana Galea· 1 shared Briony Milesi· 1 shared Carolina SalazariD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Clare L. ScottORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genomic alterations enable BRCA1 methylation loss and promoter bypass to drive resistance in high-grade serous ovarian cancer

Longyun Xu, Ksenija Nesic, Sally Beard, Jacinta L. Simmons, Xue Lu, Cassandra J. Vandenberg, Sharon M. Hoyte, Binny Jaradi, Ratana Lim, Franziska Geissler, Stacey L. Edwards, Joep Vissers, Anthony T. Papenfuss, Sean Michael Grimmond, John V. Pearson, , Olga Kondrashova

This study identifies genomic mechanisms enabling BRCA1 methylation loss and promoter bypass in ovarian cancer, leading to PARP inhibitor resistance.

bioRxiv · Jul 30, 2026 · PreprintCancer Biology

Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid models

Olivia Craig, Carolina Salazar, Suad M. Abdirahman, Nikita Dalvi, Niveditha Rajadevan, Jennii Luu, Robert Vary, Susanne Ramm, Karla J. Cowley, Ratana Lim, Briony Milesi, Christopher Tagkalidis, Patricia Wojtowicz, Stuart Bencraig, Genevieve Dall, , Kylie L. Gorringe

This paper develops a large biobank of patient-derived MOC organoids and screens them for drug efficacy, finding resistance to standard therapies and effectiveness of less commonly used drugs.

bioRxiv · Apr 9, 2026 · PreprintCancer Biology